下咽癌咽后及茎突后淋巴结转移的患病率与危险因素
回顾性分析155例接受放疗的下咽癌患者的FDG-PET/CT及增强薄层CT、MR图像,咽后淋巴结转移见于20例(13%),后壁肿瘤及双侧或对侧颈部淋巴结转移是其危险因素;茎突后淋巴结转移仅2例(1%),同侧II区上界淋巴结≥15 mm与其相关。
要点
- 下咽癌咽后淋巴结转移患病率为13%(20/155)。
- 后壁肿瘤及双侧或对侧颈部淋巴结转移与咽后淋巴结转移显著相关。
- 茎突后淋巴结转移罕见(1%),同侧II区上界淋巴结≥15 mm为危险因素。
核心结论
- 下咽癌患者中咽后淋巴结转移见于13%,后壁肿瘤和双侧或对侧颈部淋巴结转移是其危险因素,后壁肿瘤尤其与对侧咽后淋巴结转移相关。
- 茎突后淋巴结转移罕见,同侧II区上界淋巴结≥15 mm是同侧茎突后淋巴结转移的危险因素。
研究设计与样本
- 回顾性研究,由两名委员会认证的放射肿瘤科医生回顾性审阅155例接受放疗的下咽癌患者的治疗前FDG-PET/CT、增强薄层CT和MR图像。
- 采用Fisher精确检验和逻辑回归分析评估淋巴结转移的危险因素。
主要发现
- 咽后淋巴结转移确认于20例(13%)患者;后壁肿瘤(OR 4.128,95%CI 1.339-12.727,p=0.014)和双侧或对侧颈部淋巴结转移(OR 11.577,95%CI 2.135-62.789,p=0.005)与咽后淋巴结转移显著相关。
- 28例后壁肿瘤患者中9例(32%)发现咽后淋巴结转移,其中2例(7%)为同侧、3例(11%)为对侧、4例(14%)为双侧;后壁肿瘤与对侧咽后淋巴结转移显著相关(p<0.001)。
- 茎突后淋巴结转移确认于2例(1%)患者,均为同侧茎突后淋巴结转移且同侧II区上界淋巴结≥15 mm;同侧II区上界淋巴结≥15 mm与同侧茎突后淋巴结转移显著相关(p=0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We evaluated the prevalence and identified the risk factors for retropharyngeal and retro-styloid lymph node metastasis (LNM) in patients with hypopharyngeal carcinoma (HPC). This was achieved using a combination of magnetic resonance (MR) and [18 F]-fluoro-2-deoxy-D-glucose (FDG)-positron emission tomography (PET)/computed tomography (CT) images. METHODS: Two board-certified radiation oncologists retrospectively reviewed pretreatment FDG-PET/CT images and contrast-enhanced thin-slice CT and MR images of 155 patients with HPC who underwent radiotherapy. Fisher's exact tests and logistic regression analyses were performed to assess the risk factors for LNM. RESULTS: Retropharyngeal LNM (RPLNM) was confirmed in 20 (13%) patients. Posterior wall (PW) tumors (odds ratio [OR]: 4.128, 95% confidence interval [CI]: 1.339-12.727; p = 0.014) and bilateral or contralateral cervical LNM (OR: 11.577, 95% CI: 2.135-62.789; p = 0.005) were significantly correlated with RPLNM. The RPLNM was found in 9 (32%) of the 28 patients with PW tumors. Of these 9 patients, 2 (7%) had ipsilateral RPLNM, 3 (11%) had contralateral RPLNM, and 4 (14%) had bilateral RPLNM. The PW tumors were significantly associated with contralateral RPLNM (p < 0.001). Retro-styloid LNM (RSLNM) was confirmed in two (1%) patients, both of whom had ipsilateral RSLNM with lymph nodes (LNs) of ≥ 15 mm in the upper limit of ipsilateral level II. A significant association was found between LNs of ≥ 15 mm in the upper limit of ipsilateral level II and ipsilateral RSLNM (p = 0.001). CONCLUSIONS: The RPLNM was identified in 13% of patients with HPC. The PW tumors and bilateral or contralateral cervical LNM were risk factors for RPLNM; particularly, PW tumors were a specific risk factor for contralateral RPLNM. Although the RSLNM was rare, LNs of ≥ 15 mm in the upper limit of ipsilateral level II were a risk factor for ipsilateral RSLNM.
引用
- Toya R, Matsuyama T, Saito T, et al. Prevalence and risk factors for retropharyngeal and retro-styloid lymph node metastasis in hypopharyngeal carcinoma. Radiat Oncol. 2023. PMID: 37568173. doi:10.1186/s13014-023-02322-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。